Science & Research
New Book Challenges Conventional Dementia Care, Advocates for Non-Invasive Gamma Stimulation
Mark L. Fox's 'The Memory Room' presents evidence that cognitive decline may be mitigated through 40 Hz gamma stimulation, based on MIT research and a clinical study showing cognitive improvement in all 41 participants.
New AI Model Maps River Depth in Sediment-Laden Waters, Offering Flood and Management Insights
Researchers developed RivDepth, an AI-enabled method using Sentinel-2 satellite data to accurately map water depth in high-sediment rivers like the Yellow River, overcoming limitations of conventional satellite bathymetry to support flood assessment and river management.
New Book Examines How Human Behavior and Social Systems Drive Environmental Decline
David Hawk's 'Human Nature and the Potential in Nurture' explores the link between human interactions, governance, and environmental degradation through a systems science lens.
Study Links Traumatic Brain Injury to Higher Brain Cancer Mortality, Urging Long-Term Monitoring
A Mass General Brigham study found that traumatic brain injury increases brain cancer mortality risk, prompting calls for revised long-term care and highlighting implications for drug developers like CNS Pharmaceuticals.
Tonix Pharmaceuticals to Present at BTIG Infectious Disease Day 2026, Highlighting Immunology Pipeline
Tonix Pharmaceuticals will participate in BTIG Infectious Disease Day 2026, showcasing its immunology programs including a Lyme disease prophylaxis candidate, underscoring its expansion beyond CNS treatments.
National ALS Registry Seeks Participants to Unlock Disease Mysteries
The National ALS Registry, a CDC program, encourages people with ALS to enroll and complete risk factor surveys to aid research into causes and treatments, highlighting the urgent need for data to combat the disease that affects over 5,000 new Americans annually.
FIU Researchers Discover Method to Extend Immune Cell Lifespan, Potentially Boosting CAR-T Therapy Effectiveness
A new study from FIU researchers has found a way to extend the lifespan and efficacy of immune cells used in CAR-T therapy, which could improve treatment outcomes for blood cancers and potentially solid tumors.
BOXABL Unveils Rego-Brix Lunar Radiation Shielding Concept
BOXABL introduced Rego-Brix, a modular radiation-shielding system using lunar regolith to protect future moon habitats, and plans to offer the technology royalty-free as it nears a Nasdaq listing.
SureNano Science Accelerates Development of Obesity Drug GEP-44, Initiates FDA-Aligned Preclinical Studies
SureNano Science has begun GLP toxicology and pharmacology studies for its lead drug candidate GEP-44, targeting obesity and type 2 diabetes, marking a crucial step toward clinical trials and FDA approval.
War of the Havens: Volume III Escalates the Hellgate Series Into a Struggle for Civilization
The release of War of the Havens (Volume III) by Dr. Christopher Paul Milne expands the Hellgate series from a search for a botanical cure into a full-scale battle over humanity's future, drawing on the author's expertise in public health and biopharmaceutical research.
BOXABL Unveils Rego-Brix Lunar Radiation Shielding Concept Using Moon Soil
BOXABL introduces Rego-Brix, a modular radiation-shielding system that uses lunar regolith to protect future moon habitats, with potential implications for reducing space mission costs and advancing off-world construction.
New Book Examines How Industrialization Reshaped Human Systems and the Environment
David Hawk's 'Human Nature and the Potential in Nurture' explores the impact of industrialization on human systems and environmental conditions, drawing on systems sciences to analyze the transition from natural to engineered environments.
Powermax Minerals Identifies Priority Rare Earth Targets at Hopkins Project in Ontario
Powermax Minerals completed a desktop study for its Hopkins REE Project, identifying Block A as the highest-priority area and outlining multiple target zones, supporting a phased exploration program.
Helus Pharma CMO to Speak at H.C. Wainwright Neuro Perspectives Conference
Helus Pharma's Chief Medical Officer will present at a key industry conference, highlighting the company's progress in developing novel treatments for depression and anxiety.
New Book ‘Weight Loss Decoded’ Seeks to Clarify GLP-1 Medication Confusion
Sharon Polsky’s new book aims to provide clear, science-based information about GLP-1 weight loss medications, addressing common questions and misconceptions.
Ventiv Scientific's V-PULSE System Shows Promise in First Human Trials for Clot Removal
Ventiv Scientific announced successful first-in-human cases using its V-PULSE Mechanical Thrombectomy System, a novel device offering real-time aspiration control that could improve outcomes for patients with peripheral vascular clots while reducing blood loss.
Amerigo Scientific Launches Small Molecule Portfolio for Stem Cell Research and Therapy Manufacturing
Amerigo Scientific has introduced a comprehensive line of research-grade and GMP-grade small molecules to advance stem cell research, regenerative medicine, and cell therapy manufacturing, bridging fundamental research and clinical translation.
Immediate Skin-to-Skin Care Significantly Improves Survival for Preterm Infants, Review Finds
A new review in the World Journal of Pediatrics shows that immediate kangaroo mother care, started within 24 hours of birth, reduces mortality and improves health outcomes for premature and low-birth-weight newborns.
KC Lewis' 'Recurve' Blends Sci-Fi, Survival Horror, and Existential Questions in New Novel
Franklin Publishers has released 'Recurve' by KC Lewis, a science fiction thriller set in a post-First Contact Houston that explores identity, loss, and sacrifice through a protagonist who relives death.
Smart Nanoparticles Convert 'Cold' Tumors to 'Hot' in Immunotherapy Breakthrough
Scientists develop tumor microenvironment-responsive polymeric nanoparticles that precisely deliver immunotherapy, turning immunologically 'cold' tumors 'hot' and expanding treatment efficacy to more cancer patients.
Software Engineer's Memoir Chronicles Spiritual Synchronicities and 'Winks from Heaven'
Steve E. Callas's new book 'The 100 Year Old Prophet' recounts his journey from skeptic to believer, highlighting the profound impact of everyday connections and divine timing.
Grapes May Support Skin Health at Genetic Level, Study Finds
A new study suggests that consuming grapes can change gene expression in human skin, supporting healthier and more resilient skin, highlighting the importance of diet in skin care.
Study Links Breast Implant Biofilms to Chronic Inflammation and BII Symptoms
A 2024 peer-reviewed study published in MDPI's Microorganisms journal identifies bacterial biofilms on breast implants as a driver of chronic inflammation and systemic symptoms associated with Breast Implant Illness (BII), offering a clinical framework for explant surgery.
Optimi Health Completes First Psilocybin Export to UK for Phase 2 Trial
Optimi Health Corp. has exported naturally derived psilocybin to the UK for a planned Phase 2 clinical trial, marking a milestone in international psychedelic drug distribution.
Microsoft Accelerates Quantum Computing Timeline, Targets Scalable System by 2029
Microsoft has moved up its goal for a practical quantum computer from 2033 to 2029, citing a breakthrough in chip performance with the Majorana 2, amid a surge of activity in the quantum computing sector.
Low Blood Pressure Shows Strongest Link to Alzheimer's Risk in New Analysis of Nearly 800,000 Adults
A new study in the Journal of the American Heart Association finds that hypotension is most strongly associated with Alzheimer's disease among several cardiovascular conditions, with stronger effects in Black and Hispanic adults, suggesting shared biological roots.
Carmed Pharmaceuticals Publishes Second Peer-Reviewed Study of Its Carvacrol-Based Formulations
Carmed Pharmaceuticals highlights a new peer-reviewed study on its formulations Vacrol® and S-Mix® in the journal Antioxidants, underscoring its commitment to scientific research as it expands into the U.S. market.
BOXABL Unveils Folding Habitat Concept for Lunar Settlements, Keeps Royalty-Free IP
BOXABL has introduced a conceptual foldable habitat called UFO for lunar and planetary settlements, separate from its Earth-focused modular housing business, and plans to offer the IP royalty-free to spur innovation.
Quantum BioPharma Completes Phase 1 Trial for Multiple Sclerosis Therapy Lucid-MS
Quantum BioPharma announces completion of Phase 1 clinical studies for Lucid-MS, a therapy targeting myelin repair in multiple sclerosis, and submission of an IND application to the FDA.
New Guideline Redefines Weight as Key Risk Factor in Cardiovascular-Kidney-Metabolic Syndrome
The first-ever clinical guideline for cardiovascular-kidney-metabolic syndrome, issued by the American Heart Association and American College of Cardiology, reframes excess weight as a primary driver of interconnected heart, kidney, and metabolic conditions, urging earlier prevention-focused conversations and coordinated care.